Third Quarter Financial Report

15. Nov 2017 | 2 min read

Moss, 15 November 2017

Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:

  • 66% growth in sales revenue compared to 3Q16, 16 % y/y
  • New patent protection received after end of period

Please find the report for the third quarter enclosed.

 

For further information, please contact:

Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117

 
MeldingsID:  438711
 
 

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

Read more

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

Read more

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..

Read more